MCMary de Assis Carvalho

Mary de Assis Carvalho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mary de Assis Carvalho has a total of 56 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence of Functional Constipation in Children with Down Syndrome: A Study Conducted at a General Pediatrics Service

    by Ana Maria Daun Cação Pereira, Catarina Shin, Ana Beatriz Henrique Parenti, Mary de Assis Carvalho, Cátia Regina Branco Fonseca

    Background/Objectives: Gastrointestinal and eating disorders are highly prevalent problems in children with Down syndrome (DS) and have a significant impact on their daily lives. It is important to investigate the bowel habits of children with DS, specifically the prevalence of functional constipation (FC), in order to develop practice guidelines for pediatricians that support diagnosis and treatment. Materials and Methods: This observational, analytical, and cross-sectional study was approved by the Ethics Committee and included 36 children with DS under pediatric outpatient follow-up at a university hospital. To assess bowel habits, an interview was held with the parents using the Rome IV criteria and the Bristol Stool Scale. The children were divided into two groups: those with and those without FC. Specific curves for individuals with DS were used for nutritional assessment. Results: The median age of the children was 46.6 months (5 to 144 months); a total of 80.5% of those included were eutrophic. The median age at initiation of toilet training was 36 months. Most children achieved bowel control when training started after 30 months of age. A total of 15 (41.7%) of the 36 children included were assigned to the group with FC, and 21 (58.3%) were assigned to the group without FC. The FC group had a lower frequency of bowel movements, hardened stools, pain during bowel movement, and used laxatives. According to the Rome IV criteria, the three most prevalent criteria were hard stools, large-volume stools, and painful bowel movements. Conclusions: Children with DS had a high prevalence of FC, and it was possible to identify an association between delayed sphincter training and FC. A care and monitoring protocol and flowchart are useful tools for the general pediatrician.


  • Open Access

    Diagnostic delay in very early-onset inflammatory bowel disease: A tertiary single-center retrospective study

    by Juliana Tedesco Dias, Debora Avellaneda Penatti, Jessika Alves de Souza Costa, Gabriela Nascimento Hercos, Carine Dias Ferreira de Jesus, Mary de Assis Carvalho, Nilton Carlos Machado

    Background: Very early-onset inflammatory bowel disease (VEO-IBD) may have an aggressive clinical course. Upon suspicion, an immediate transfer to a pediatric gastroenterology clinic should be made, considering that diagnostic delay (DD) in referral can have profound implications. Objectives: The objectives of the study are to investigate the time, proportion, and factors associated with DD in VEO-IBD and explore the symptoms at initial presentation. Methods: An observational, retrospective, single-center study of consecutive patients with VEO-IBD confirmed by histopathology was conducted. We measured the time to diagnosis—the interval between symptom onset and the final VEO-IBD diagnosis. DD was defined as the time to diagnosis that exceeded the 75th percentile. Results: Twenty-five children with VEO-IBD—16 with ulcerative colitis (UC) and 9 with Crohn’s disease (CD)—were evaluated, with a median age of 34 months. Ages at first symptoms, first visit, and diagnosis were significantly lower for the CD group. However, there was no significant difference in the time from first symptoms to diagnosis between CD and UC. Patients with weight loss, anemia, and fistulas did not meet established criteria for DD and were referred early. Conclusion: Our study underscores the importance of early recognition of VEO-IBD, with bloody diarrhea, abdominal pain, and weight loss serving as crucial warning signs. Identifying these symptoms can aid in the early diagnosis and prompt referral to a specialist, potentially reducing the risk of DD. Relevance for patients: Early recognition of bloody diarrhea, abdominal pain, and weight loss in young children can speed diagnosis of VEO-IBD and ensure timely referral to specialist care.

  • Open Access

    The primary nutritional approach in pediatric celiac disease: a mini-review

    by Nilton Carlos Machado, Thabata Koester Weber, Juliana Tedesco Dias, Gabriela Nascimento Hercos, Carine Dias Ferreira de Jesus, Mary de Assis Carvalho

    Background: Celiac disease (CD) is chronic small bowel inflammation with villous atrophy, consequently, an immune-mediated disorder triggered by ingesting Gluten in wheat, barley, and rye in genetically susceptible individuals. Aims: Summarize the fundamental principles for managing the diet of patients with CD. This Mini-Review using relevant articles in PubMed's online databases followed the medical keywords Celiac Disease, Gluten, gluten-free diet, nutritional approach, and diet adherence. The institution's Ethics Committee has waived the need to review the ethical aspects of this text. The cornerstone of the treatment is the lifelong adherence to a Gluten-Free Diet (GFD). This dietary regimen, which forms the basis of the patient's treatment, requires eliminating all food components containing Gluten and its derivatives from the diet. However, the treatment approach has changed from focusing on food avoidance to a wide-ranging evaluation of the various factors influencing the dietary choices in the patient's life. The Global Approach to the Follow-up of Celiac Disease is based on 1) control of symptomatology and dietary adherence; 2) improving emotional and social wellness in treating CD patients, with the active involvement of a psychologist; and 3) ensuring successful education of both the child and the family about its management. Indeed, the impact of CD extends beyond the patient and affects the well-being of caregivers and 4) evaluate socioeconomic burden, considering that Gluten-free food products remain significantly more expensive than gluten-containing equivalents with variable availability. So, the GFD is the primary treatment for CD, and difficulties in managing the Disease can lead to impaired Quality of Life. In conclusion, strict adherence to the GFD is imperative, requiring a multidisciplinary team involving physicians, dietitians, and psychologists on a regular visit schedule to assess dietary adherence and avoid long-term complications.


  • Open Access

    Transcutaneous Posterior Tibial Nerve Stimulation: An Adjuvant Treatment for Intractable Constipation in Children

    by Rebeca Mayara Padilha Rego, Nilton Carlos Machado, Mary de Assis Carvalho, Johann Souza Graffunder, Crhistiano Fraguas, Erika Veruska Paiva Ortolan, Pedro Luiz Toledo de Arruda Lourenção

    Background: Functional constipation can lead to painful defecations, fecal incontinence, and abdominal pain, significantly affecting a child’s quality of life. Treatment options include non-pharmacological and pharmacological approaches, but some cases are intractable and require alternative interventions like neuromodulation. A subtype of neuromodulation, called Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS), comprises electrical stimulation at the ankle level, by means of electrodes fixed to the skin. TPTNS is a minimally invasive, easy-to-apply technique that can potentially improve constipation symptoms in the pediatric population by stimulating the sacral nerves. Aim: To evaluate the clinical results and applicability of TPTNS as an adjuvant treatment for children and adolescents with functional constipation. Methods: Between April 2019 and October 2021, 36 patients diagnosed with functional constipation according to the Rome IV Criteria were invited to participate in the study. The study followed a single-center, uncontrolled, prospective cohort design. Patients received TPTNS for 4 or 8 weeks, with assessments conducted immediately after the periods of TPTNS and 4 weeks after the end of the intervention period. The data normality distribution was determined by the Shapiro–Wilk test. The Wilcoxon test and Student’s t-test for paired samples were used to compare quantitative variables, and the McNemar test was used to compare categorical variables. Results: Of the 36 enrolled patients, 28 children and adolescents with intractable function constipation completed the study, receiving TPTNS for 4 weeks. Sixteen patients (57.1%) extended the intervention period for 4 extra weeks, receiving 8 weeks of intervention. TPTNS led to significant improvements in stool consistency, frequency of defecation, and bowel function scores, with a reduction in abdominal pain. Quality of life across physical and psychosocial domains showed substantial enhancements. The quality of life-related to bowel habits also improved significantly, particularly in lifestyle, behavior, and embarrassment domains. The positive effects of this intervention are seen relatively early, detected after 4 weeks of intervention, and even 4 weeks after the end of the intervention. TPTNS was well-tolerated, with an adherence rate of approximately 78%, and no adverse effects were reported. Conclusions: TPTNS is an adjuvant treatment for intractable functional constipation, improving bowel function and quality of life. The effects of TPTNS were observed relatively early and sustained even after treatment cessation.


  • Open Access

    Transcutaneous posterior tibial nerve stimulation: an adjuvant treatment for intractable constipation in children

    by Rebeca Mayara Padilha Rego, Nilton Carlos Machado, Mary de Assis Carvalho, Johann Souza Graffunder, Crhistiano Fraguas, Erika Veruska Paiva Ortolan, Pedro Luiz Toledo de Arruda Lourenção

    BACKGROUND: Functional constipation can lead to painful defecations, fecal incontinence, and abdominal pain, significantly affecting a child's quality of life. Treatment options include non-pharmacological and pharmacological approaches, but some cases are intractable and require alternative interventions like neuromodulation. A subtype of neuromodulation, called Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS), comprises electrical stimulation at the ankle level, by means of electrodes fixed to the skin. TPTNS is a minimally invasive, easy-to-apply technique that can potentially improve constipation symptoms in the pediatric population by stimulating the sacral nerves. AIM: To evaluate the clinical results and applicability of TPTNS as an adjuvant treatment for children and adolescents with functional constipation. METHODS: Between April 2019 and October 2021, 38 patients diagnosed with functional constipation according to the Rome IV Criteria were invited to participate in the study. The study followed a single-center, uncontrolled, prospective cohort design. Patients received TPTNS for 4 or 8 weeks, with assessments conducted immediately after the periods of TPTNS and 4 weeks after the end of the intervention period. The data normality distribution was determined by the Shapiro-Wilk test. Wilcoxon test and Student's t-test for paired samples were used to compare quantitative variables, and the McNemar test was used to compare categorical variables. RESULTS: Of the 38 enrolled patients, 28 children and adolescents with intractable function constipation completed the study, receiving TPTNS for 4 weeks. Sixteen patients (57.1%) extended the intervention period for 4 extra weeks, receiving 8 weeks of intervention. TPTNS led to significant improvements in stool consistency, frequency of defecation, and bowel function scores, with a reduction in abdominal pain. Quality of life across physical and psychosocial domains showed substantial enhancements. The quality of life-related to bowel habits also improved significantly, particularly in lifestyle, behavior, and embarrassment domains. The positive effects of this intervention are seen relatively early, detected after 4 weeks of intervention, and even 4 weeks after the end of the intervention. TPTNS was well-tolerated, with an adherence rate of approximately 78%, and no adverse effects were reported. CONCLUSION: TPTNS is an adjuvant treatment for intractable functional constipation, improving bowel function and quality of life. The effects of TPTNS were observed relatively early and sustained even after treatment cessation.

  • Open Access

    Functional constipation in the first-year-old onset at the first visit to a specialized clinic elicits a delay in referrals, the worst symptoms, and the excessive use of rectal laxatives

    by Mary de Assis Carvalho, Juliana Tedesco Dias, Andrea Catherine Quiroz Gamarra, Cristian E Moreno Sandoval, José Hermann Avendaño Caraballo, Nilton Carlos Machado

    Purpose: To assess and compares sociodemographic, clinical, anthropometric, and treatment characteristics in two subgroups of children with FC: 1) with onset in the first 12 months old and 2) with onset after 13 months old. Methods: Observational, retrospective cohort study, including consecutive cases of children/adolescents for initial evaluation of constipation. Data were collected in a predesigned standard protocol, and the parents answered all the questions during the first visit. Inclusion criteria: age between 01 month to 15 years of age, with a diagnosis of FC defined according to the Rome Criteria III and Rome IV criteria. Exclusion criteria: constipation of organic etiology; other chronic health problems such as neurological, genetic, mental/ psychiatric disorders or growth and development disorders. The stool form was evaluated according to Bristol Stool Form Scale. Two experienced pediatric gastroenterologists determined the patients’ final diagnoses of FC. Approval was obtained from the ethics committee. Results: Five hundred and four children were identified with constipation at their initial visit. Thirty-two were excluded based on the inclusion and exclusion criteria. The remaining 472 children (225 with onset within the first 12 months and 247 after 13 months) were included. There was a long time to first visit in those with onset in the first 12 months of life. There is no difference in BMI/age scores between the two groups. FC onset in the first 12 months has more scybalous stools, painful defecation, bloody stools, a lower proportion with bowel toilet training, and bladder control. In FC starting in the first 12 months of life, only half of the children (55%) were treated with laxatives, and an entire group used rectal treatment. Conclusion: FC is a common Functional Gastrointestinal Disorder affecting infants during the first months of life. The primary inadequate treatment and referral delay implies worsening symptoms, chronicity, and non-implementing North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines.

  • Open Access

    Impaired Health-Related Quality of Life in Brazilian Children with Chronic Abdominal Pain: A Cross-Sectional Study

    by Carine Dias Ferreira de Jesus, Mary de Assis Carvalho, Nilton Carlos Machado

    De Jesus CD, et al. Pediatr Gastroenterol Hepatol Nutr. 2022 Nov;25(6):500-509. https://doi.org/10.5223/pghn.2022.25.6.500


  • Open Access

    Obesity/overweight in functional abdominal pain disorders: high prevalence in children with irritable bowel syndrome

    by Mary de Assis Carvalho, Andréa Souza Hachem, Rafaella Karen Sousa Monterlei, Debora Avellaneda Penatti, Juliana Tedesco Dias, Miriam Hashimoto, Nilton Carlos Machado


  • Open Access

    "Comparison of two self-report pain intensity scales in children and adolescents with chronic abdominal pain associated with Helicobacter pylori-dyspepsia and Irritable bowel syndrome"

    by Nilton Carlos Machado, Mary de Assis Carvalho, Carine Dias Ferreira de Jesus, Debora Avellaneda Penatti, Juliana Tedesco Dias

    Purpose: To evaluate pain intensity and the agreement between the Visual Analogue Scale (VAS) and Faces Pain Scale (FAS) in children/adolescents with Chronic Abdominal Pain (CAP) both in Irritable Bowel Syndrome (IBS) and Helicobacter pylori dyspepsia (HpD). Methods: Single-centre, observational, cross-sectional study including 217 children/ adolescents. Inclusion criteria: age (4-15 years); HpD diagnosis established with endoscopy and histopathological biopsies. IBS diagnosis based on Rome IV criteria. Exclusion criteria: chronic disorders (genetic, metabolic, cardiac, hepatic, renal diseases). In a standardized form, data was achieved, and children marked the “pain over the past month”. Results: The age of first symptoms, first visits, pain (epigastric, retrosternal, nocturnal pain, burning), vomiting, and anorexia were higher in HpD than in IBS children. The pain intensity was categorized as severe (7-10) for the majority of children both in FAS and VAS scales (p>.0.05). Also, analysis between IBS and HpD concerning sex, first child, age at first visit (≤10 y or >10y), overweight/obese, average BMI child, and the number of episodes of pain during the week (p>0.05). There was a positive and statistically significant correlation between FAS and VAS pain intensity in IBS (All children, male and female) and HpD group (only for All children). On Bland-Altman plots of VAS vs FAS, the 2SD values of differences between scales were: IBS (3.8) and HpD (3.4) group. The calculated limits of agreement (95% CIs) exceeded the a priori limits of acceptability for all measured parameters, indicating that the scales are not interchangeable. Conclusions: Pain scales were, without difficulty performed, widely accepted and provided evidence that FAS and VAS are valid measures for assessing pain intensity in children with CAP. However, both VAS and FAS did not discriminate IBS from HpD, and the scales are not interchangeable.

  • Open Access

    Rotulagem de alérgenos alimentares em alimentos embalados segundo grupos alimentares da pirâmide brasileira: análise da descrição, riscos e ambiguidades

    by Joice Ferreira Lopes, Mary de Assis Carvalho, Nilton Carlos Machado

    RESUMO Objetivo: Avaliar os componentes alergênicos da rotulagem de alimentos embalados e responder “Qual é a qualidade da rotulagem?” e “Qual é o grupo de alimentos em que a expressão ‘Pode conter’ é predominante?”. Métodos: Foram obtidas fotografias de 916 produtos, dos quais 518 foram analisados. Os dados dos rótulos foram avaliados de acordo com os grupos da pirâmide alimentar brasileira (Cereais, Frutas & Vegetais; Soja & Derivados; Leite & Laticínios; Carne & Ovos; Gorduras & Óleos; Açúcares & Doces). Dez itens foram analisados nos rótulos: presença de lista de ingredientes; frase de alerta para alérgicos; frase de alerta; local da frase; frase em letras maiúsculas; frase em negrito; a cor da frase de alerta contrastando com o fundo; tamanho de fonte adequado; não alegar ausência de qualquer alérgeno; outros fatores de difícil leitura. Para a segunda questão, foi respondido questionário estruturado, e os produtos classificados em categorias: “Contém” e “Pode conter”. Resultados: A qualidade do rótulo foi adequada e 69% dos alimentos embalados continham pelo menos um alérgeno. A informação “Pode conter” foi mais identificada em: proteína do leite (Cereais e Carnes e ovos), soja (Soja & derivados) e proteína do ovo (Cereais). Soja e derivados foi o grupo alimentar de maior insegurança. Conclusões: Profissionais de saúde podem contar com rotulagem de boa qualidade dos produtos embalados e, consequentemente, promover a educação de pais/cuidadores para consultar os rótulos e gerenciar os riscos em alimentos processados. Soja e produtos são os alimentos com maior insegurança entre os Grupos da Pirâmide Brasileira.